International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.

Saved in:
Bibliographic Details
Title: International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.
Authors: Novis E; Melanoma Institute Australia, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; The Royal Marsden Hospital, London, UK., Rautalin M; Melanoma Institute Australia, Sydney, NSW, Australia.; Department of Plastic Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Amaria RN; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Blank CU; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Faries MB; The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA, USA., Grunhagen DJ; Erasmus MC, Rotterdam, The Netherlands., Gyorki DE; Division of Cancer Surgery, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Hayes AJ; The Royal Marsden Hospital, London, UK., Kuijpers AMJ; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Long GV; Melanoma Institute Australia, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Mammen JMV; Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA., Menzies AM; Melanoma Institute Australia, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Ross MI; Department of Surgical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Tawbi HA; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Departments of Pathology and Dermatology; Dermatopathology and Oral Pathology Unit, University of California San Francisco, San Francisco, CA, USA., Zager JS; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Wargo JA; Department of Surgical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Hieken TJ; Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA., van Akkooi ACJ; Melanoma Institute Australia, Sydney, NSW, Australia. Alexander.vanakkooi@melanoma.org.au.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. Alexander.vanakkooi@melanoma.org.au.; Department of Melanoma and Surgical Oncology, Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia. Alexander.vanakkooi@melanoma.org.au.
Corporate Authors: International Neoadjuvant Melanoma Consortium (INMC)
Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Mar; Vol. 33 (3), pp. 2571-2578. Date of Electronic Publication: 2025 Oct 14.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1534-4681
DOI:10.1245/s10434-025-18475-3